Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Short vs Prolonged Infusion of Ceftolozane-tazobactam in VAP
NCT03581370Phase 3Recruiting
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Sep 2018
- Primary completion
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ceftolozane + tazobactam in ventilator-associated pneumonia (VAP), sponsored by Centre hospitalier universitaire de Toulouse. Started Sep 2018; status: recruiting.
02
Drugs
ceftolozane + tazobactam
03
Conditions
ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on NCT03581370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03581370.